<ul><li>Starget Pharma, an innovative startup specializing in precision cancer diagnostics and targeted radiotherapy, has secured $5.1M in funding from Cancer Focus.</li><li>The funding will support Starget Pharma's upcoming clinical trial for treating advanced metastatic cancers, including sarcomas, neuroendocrine tumors, melanoma, and liver cancer.</li><li>Starget Pharma is developing radioligand-based therapies that target tumor cells with focused radiation, minimizing damage to surrounding healthy tissue.</li><li>Their AI-driven platform combines diagnostic imaging with targeted radiotherapy to create personalized treatment plans, offering improved outcomes compared to traditional radiotherapy.</li></ul>

Starget Pharma Secures $5.1M for AI-Powered Targeted Radiotherapy for Cancer

Discover more